Last reviewed · How we verify

NCT06799962: ARCADIA-VR

AI and VR Devices for Eating Behavior Rehabilitation

Recruiting now NA Last updated 30 April 2025
What this trial tests

NA trial testing Enhanced Body-Swap for Anorexia Nervosa in Eating Disorders in 80 participants. Currently enrolling.

Timeline
30 January 2025
Primary endpoint
30 July 2025
31 January 2026

Quick facts

Lead sponsorIstituto per la Ricerca e l'Innovazione Biomedica
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment80
Start date30 January 2025
Primary completion30 July 2025
Estimated completion31 January 2026
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Istituto per la Ricerca e l'Innovazione Biomedica — full company profile →

Who can join

Adults 15 to 40, any sex, with Eating Disorders or Anorexia Nervosa. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Eating disorders (ED) affect the relationship with food and body image. Virtual reality (VR), combined with artificial intelligence (AI), offers new clinical solutions, overcoming traditional cognitive behavioral therapy (CBT). The ARCADIA VR project aims to develop devices to treat ED through personalized VR systems (e.g. Enhanced Body-Swap for anorexia, Emotional Rescripting for bulimia) and AI predictive algorithms to monitor severity, risk and efficacy of treatments. These approaches promise better and faster results, improving diagnosis and treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Eating Disorders

Currently open trials in the same condition.

Other Istituto per la Ricerca e l'Innovazione Biomedica trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06799962.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing